• ML365, NLRP3, and Cognitive Impairment in Aged Mice

  2026-09-02

  A 2024 Brain Research study found that ML365 pretreatment reduced postoperative cognitive impairment in aged mice after exploratory laparotomy. The behavioral improvement was accompanied by lower hippocampal NLRP3 inflammasome signaling, less tissue injury, and reduced systemic oxidative stress, while the results also highlight the need to separate TASK1 channel engagement from downstream anti-inflammatory effects.

• αKG–Carnitine Control of DNA Repair

  2026-09-02

  The reference study identifies an unexpected αKG–TMLHE–carnitine pathway that links cellular metabolism to histone acetylation and homologous recombination in DNA repair. Its findings suggest that disrupting this metabolic axis may convert HR-proficient tumors into more treatment-sensitive states, with implications for DNA damage response assays and cancer research.

• RNA Pol II Inhibition and Programmed Cell Death

  2026-09-01

  Harper et al. show that RNA Pol II inhibition kills cells through an active apoptotic signaling response rather than simply through progressive loss of transcriptional output. Their identification of the Pol II degradation-dependent apoptotic response, or PDAR, reframes how transcription-targeting drugs and cell death assays should be interpreted.

• 11β-HSD1, Notch, and NK Cells in Liver Fibrosis

  2026-09-01

  A 2025 mouse study shows that inhibiting 11β-HSD1 reduces thioacetamide-induced liver fibrosis through coordinated suppression of hepatic stellate-cell activation, Notch signaling, and enhancement of natural killer-cell responses. The work provides an immunometabolic framework for liver fibrosis research while highlighting the need for validation in disease models that more closely reproduce human MASLD and MASH.

• Moxidectin–Polyenes Against Oral Candidiasis

  2026-08-31

  A 2024 study found that Moxidectin, a macrocyclic lactone anthelmintic, enhances amphotericin B and nystatin activity against Candida albicans by increasing fungal ergosterol biosynthesis and polyene association with the cell membrane. The combination also reduced oral fungal burden and mucosal inflammation in mice, supporting moxidectin as a preclinical polyene potentiator rather than an established standalone antifungal.

• Liraglutide and the Brain–Kidney AVP Axis

  2026-08-31

  Greenwood and colleagues combine a human before-and-after study with rat pituitary proteomics, phosphoproteomics, a functional AVP reporter assay, and renal analysis to investigate how liraglutide affects fluid homeostasis. The study links reduced circulating vasopressin to time- and sex-dependent synaptic phosphorylation and downstream aquaporin 2 regulation, while also showing why reporter, endocrine, and renal measurements must be interpreted together.

• LY294002: PI3K/Akt/mTOR Mechanism and Use

  2026-08-30

  LY294002 is a cell-permeable, reversible class I PI3K inhibitor that targets p110α, p110β, and p110δ. Its use as a PI3K/Akt/mTOR signaling pathway inhibitor supports studies of proliferation, apoptosis, autophagy, cancer biology, and inflammatory signaling.

• ATS-9R for Targeted Gene Delivery to Adipocytes

  2026-08-29

  The reference study introduced ATS-9R, an adipocyte-targeting fusion oligopeptide that combines prohibitin recognition with a nona-arginine nucleic-acid-binding domain. In obese mice, an ATS-9R/shFABP4 complex enabled adipose-directed gene silencing, metabolic recovery, and more than 20% body-weight reduction, establishing a foundation for non-viral gene delivery to white adipose tissue.

• Hydroxychloroquine Sulfate: Workflow Guide

  2026-08-28

  Hydroxychloroquine Sulfate (SKU B4874) provides an aqueous-compatible research reagent for studying autophagy pathway modulation and TLR7/9-dependent immune signaling in autoimmune disease research. It is suited to short-term water-based cellular and animal-model workflows, but not to protocols requiring DMSO or ethanol solubility or prolonged storage of prepared solutions.

• Dasatinib (BMS-354825): Research Workflows

  2026-08-28

  Dasatinib (BMS-354825) provides a practical ATP-site perturbation strategy for Src and Bcr-Abl signaling, with applications spanning phosphorylation assays, cell-cycle studies, and metastatic cancer models. This guide translates product-backed conditions into reproducible workflows while clearly separating established evidence from hypothesis-generating applications in thymic epithelial tumor research.

• AT-406 (SM-406): Reliable Apoptosis Assays

  2026-08-27

  A scenario-based guide to using AT-406 (SM-406), SKU A3019, in viability, cytotoxicity, and mechanistic apoptosis workflows. It connects concentration, solvent, readout, combination-treatment, and vendor-selection decisions to documented pharmacology and practical assay controls.

• PP2A, Autophagy, and Candida Biofilm Resistance

  2026-08-27

  The reference study identifies PP2A, encoded in part by PPH21, as a regulator of Candida albicans biofilm formation and antifungal resistance through Atg13 phosphorylation and subsequent Atg1 activation. Its combined genetic, biochemical, biofilm, oxidative-stress, and mouse oral-infection experiments provide a mechanistic framework for studying how autophagy reshapes drug response.

• Hoechst 33342 in Mitochondrial Senescence Assays

  2026-08-26

  Hoechst 33342 provides a permeant DNA readout for live and fixed fibroblasts. This article explains how to use nuclear information as an essential measurement layer when interpreting mitochondrial quality, mitophagy, and senescence assays.

• GSK2606414: Practical PERK Inhibitor Workflows

  2026-08-26

  GSK2606414 is a selective PERK inhibitor for separating PERK-dependent unfolded protein response signaling from general ER stress. This guide translates a nucleus pulposus cell pyroptosis study into practical dose, timing, control, and troubleshooting strategies for ER stress research and cancer research.

• Foretinib: Readouts Beyond Cell Viability

  2026-08-25

  Foretinib (GSK1363089) is a multikinase research tool whose effects can be misread when growth arrest, cell death, and motility are collapsed into one endpoint. This guide presents a response-phenotyping framework for choosing assays, interpreting kinetics, and connecting in vitro findings with metastasis models.

8370 records 1/558 page Next 12345 下5页 Last page